Defencath
Product Images NDC 72990-105

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Defencath (NDC 72990-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cormedix Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Defencath 1)

Chemical structure of the active ingredient in DEFENCATH, showing a molecule with two sulfonamide groups (O=S=O) connected to nitrogen-containing rings.*

FDA Label Image

Figure2 (Defencath 2)

Chemical structure of DEFENCATH active ingredient depicting multiple sugar rings with sulfate, hydroxyl, and amine functional groups, showing a complex polysaccharide molecule consistent with drug's composition.*

FDA Label Image

Figure3 (Defencath 3)

DEFENCATH 40.5 mg/3 mL and 3000 USP Units/3 mL vial carton label. The label indicates the product contains Taurolidine and Heparin Catheter Lock Solution in 3 mL single-dose vials, with a package size of 10 vials. The label specifies usage for instillation in central venous catheters only and includes storage instructions. Manufactured by CorMedix Inc.*

FDA Label Image

Figure4 (Defencath 4)

Label for DEFENCATH Taurolidine and Heparin Catheter Lock Solution showing strengths of 40.5 mg/3 mL for Taurolidine and 3,000 USP Units/3 mL for Heparin. The label indicates the product is for instillation in central venous catheters, not for systemic administration, and not to be used as a catheter lock flush. It is a 3 mL fill single-dose vial by CorMedix Inc.*

FDA Label Image

Figure3 (Defencath 5)

Packaging label for DEFENCATH Taurolidine and Heparin Catheter Lock Solution, 5 mL single-dose vials. The label indicates active ingredients Taurolidine 67.5 mg/5 mL (13.5 mg/mL) and Heparin 5,000 USP Units/5 mL (1,000 USP Units/mL), derived from porcine intestinal mucosa. Distributed by CorMedix Inc., the carton contains 10 single-dose vials. The label includes usage warnings, storage instructions, and NDC 72990-105-10.*

FDA Label Image

Figure4 (Defencath 6)

DEFENCATH Taurolidine and Heparin Catheter Lock Solution, containing 67.5 mg/5 mL Taurolidine and 5,000 USP Units/5 mL Heparin, is shown on this label. It is a 5 mL single-dose vial for instillation in central venous catheters. The label includes storage conditions (20°C to 25°C), manufacturer (CorMedix Inc.), and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.